SOPHiA GENETICS officer proposes $49.8K share sale
The proposed shares were acquired when restricted stock units vested on October 2 and October 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SOPHiA GENETICS SA (SOPH) officer Daan Guido Maria Van Well reported a proposed sale of 6,168 common shares, with an aggregate market value of $49,775.76 and an approximate sale date of October 5, 2026, through Morgan Stanley Smith Barney LLC on NASDAQ. The shares were acquired upon vesting of restricted stock units on October 2 and October 3, 2026. The notice also lists a September 11, 2026 sale of 6,168 common shares for gross proceeds of $47,088.98 as 10b5-1 sales.
Key Figures
Key Terms
restricted stock units financial
10b5-1 Sales financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.